Indicators on γ-Aminobutyric acid You Should Know
123). It is notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This suggests that GLS2 could confer resistance to GLS1-precise inhibitors, such as the allosteric inhibitor BPTES or CB-839, which resistance could be hypothetically prevented by the usage of a